-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Guardant Health, Raises Price Target to $200

Benzinga·07/31/2026 19:03:24
Listen to the news
RBC Capital analyst Dan Leonard maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $185 to $200.